Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03249779 · ClinicalTrials.gov registry record · NA

Treatment of RLS/WED Symptoms Through Sensory Counter-stimulation

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
8
Enrollment target

NCT03249779: Completed NA study, sponsored by Mayo Clinic.

NCT03249779 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03249779, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
8 participants
Enrollment target

Study Summary

To evaluate, in a pilot fashion, efficacy and tolerability of electrical counter-stimulation using the Scrambler device in alleviating uncomfortable sensations and urge to move in patients with restless legs syndrome/Willis Ekbom Disease (RLS/WED).

Primary Outcome

The International Restless Legs Syndrome Rating Scale (IRLS) questionnaire will be used for this purpose. The IRLS is a validated patient-reported outcome measure to accurately assess disease severity of restless legs syndrome. It has questions on the primary features of restless legs syndrome, along with intensity and frequency, associated sleep problems. For this study subjects were asked to answer 10 questions on how often they experienced each symptom, using a score of 0-4, 0 being "None" a

Interventions

  • DEVICE Scrambler

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2016-12
Est. Completion 2018-06
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT03249779 record still lists

NCT03249779 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Scrambler is the first listed.

NCT03249779 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03249779 about?

NCT03249779 is a clinical study titled "Treatment of RLS/WED Symptoms Through Sensory Counter-stimulation". To evaluate, in a pilot fashion, efficacy and tolerability of electrical counter-stimulation using the Scrambler device in alleviating uncomfortable sensations and urge to move in patients with restless legs syndrome/Willis Ekbom Disease (RLS/WED).

What is the current status of trial NCT03249779?

This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2016-12. Estimated completion is 2018-06.

What interventions are being tested in trial NCT03249779?

The interventions under investigation include: Scrambler (DEVICE).

Who is sponsoring clinical trial NCT03249779?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03249779's enrollment target sits among peer trials

8 1976th of 2000 higher than 19 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT03249779, the US trial registry maintained by the National Library of Medicine. NCT03249779 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.